fda
4 records
FDA Drug Recall: Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 30 count (NDC 7
2020-11-11
Class II — CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
View Source
FDA Drug Recall: Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle,
2020-11-11
Class II — CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
View Source
FDA Drug Recall: Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-c
2020-01-29
Class II — CGMP Deviations: Presence of NDMA impurity detected in product.
View Source
FDA Drug Recall: Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-c
2020-01-29
Class II — CGMP Deviations: Presence of NDMA impurity detected in product.
View Source
ny_corps
1 records
NY Corp: DENTON PHARMA, INC.
2016-07-15
DOMESTIC BUSINESS CORPORATION | County: Schoharie | Jurisdiction: New York
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.